Results 241 to 250 of about 38,272 (314)

Phytotherapeutic Supplementation with Momordica charantia: Beneficial Effects in Patients with Suboptimal Glycemic Control on Double Antidiabetic Therapy-A Real-World Evidence Observational Study. [PDF]

Nutrients
Vesa CM, Ghitea TC, Radu A, Radu AF, Bodog TM, Bodog RF, Brata RD, Bustea C.   +7 more
europepmc   +1 more source

The application of machine learning in the evaluation of urinary tract infections incidence in patients in a Nursing and Treatment Facility. [PDF]

Pharmacol Rep
Grzegorzek U, Sobiak J, Jaworucka E, Sznek B, Czyrski A.   +4 more
europepmc   +1 more source

Optimization and validation of UPLC method for dapagliflozin and candesartan cilexetil in an on-demand formulation: Analytical quality by design approach

Ehab M. Elzayat, Hanaa M. Kasem, Doaa Hasan Alshora, Mohammad A. Altamimi   +3 more
openalex   +1 more source

Dapagliflozin to Reduce Early Recurrence After Catheter Ablation for Atrial Fibrillation: The DARE-AF Randomized Clinical Trial. [PDF]

Circulation
Jiang C, Zhao Z, Yang Z, Wang Y, Xu Y, Xu H, Guo H, Wang C, He L, Xia S, Kong X, Dai W, Zhang J, Zuo S, Liu X, Guo X, Liu N, Li S, Zhou N, Jiang C, Tang R, Sang C, Zei PC, Long D, Du X, Dong J, Macle L, Ma C.   +27 more
europepmc   +1 more source

Dapagliflozin modulates plasma lipidomic profile and urinary metabolite excretion in type 2 diabetes. [PDF]

Cardiovasc Diabetol
Pezzica S, Pratesi F, Sabatini S, Carli F, Mengozzi A, Solini A, Gastaldelli A.   +6 more
europepmc   +1 more source

The effect of SGLT2 inhibitor and HIF-PHI on the podocyte-specific molecules and cytoskeleton of diabetic podocytes. [PDF]

BMC Nephrol
Li C, Ng JKC, Chan GCK, Fung WWS, Chow KM, Szeto CC.   +5 more
europepmc   +1 more source

Comparative efficacy and safety of different SGLT2 inhibitor-based combination strategies in HFrEF: a systematic review and network meta-analysis. [PDF]

Front Endocrinol (Lausanne)
Jiang N, Zhang Y, Tang Y, Tan H.
europepmc   +1 more source

The effect of dapagliflozin in Chinese elderly patients with heart failure. [PDF]

J Geriatr Cardiol
You J, Zheng JZ, Liu J, Gu X, Zhu Y.
europepmc   +1 more source

Improvement of Cardiometabolic Control with Dapagliflozin in Patients with Type 2 Diabetes in Primary Care: The AGORA-AP Study. [PDF]

Medicina (Kaunas)
Pallarés-Carratalá V, Ruiz-García A, Fragoso AS, Escobar-Cervantes C, Cervera-Pérez MI, Alonso-Moreno FJ, Arranz-Martínez E, Barquilla-García A, Rey-Aldana D, Polo-García J, Cinza-Sanjurjo S.   +10 more
europepmc   +1 more source